Showing results (471-480 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|April 3, 2008
Optimizing long-term therapy for Parkinson disease: options for treatment-associated dyskinesiaMark Stacy, Andrew GalbreathClinical Neuropharmacology|March 10, 2017
Bilateral Retrobulbar Optic Neuropathy Associated With GolimumabMarta de Frutos-Lezaun, Aritz Bidaguren, Patricia de la Riva, et al.Clinical Neuropharmacology|March 29, 2019
Factors Associated With Delirium in Surgical Intensive Care Unit Patients Treated With Supplemental Melatonin: A Case-Cohort StudyJoseph M Cusimano, Sarah Welch, Silvia Perez-Protto, et al.Clinical Neuropharmacology|November 16, 2012
Eslicarbazepine acetate in the management of refractory bipolar disorderKamal Nath, Arnab Bhattacharya, Samir Kumar PraharajClinical Neuropharmacology|January 18, 2014
Safety and efficacy of tolcapone in the long-term use in Parkinson disease: an observational studyKarla Eggert, Wolfgang H Oertel, Andrew J Lees, et al.Clinical Neuropharmacology|January 18, 2014
Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized studyMurat Emre, Werner Poewe, Peter Paul De Deyn, et al.Clinical Neuropharmacology|May 15, 2014
A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorderMaria Urbano, Leonore Okwara, Paul Manser, et al.Clinical Neuropharmacology|May 15, 2014
The effect of lithium in post-stroke motor recovery: a double-blind, placebo-controlled, randomized clinical trialSeyed Ehsan Mohammadianinejad, Nastaran Majdinasab, Seyed Aidin Sajedi, et al.Clinical Neuropharmacology|May 15, 2014
Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs-an open-label studyRafael Stryjer, Dana Budnik, Tania Ebert, et al.Clinical Neuropharmacology|September 19, 2012
Co-occurring psychotic and addictive disorders: neurobiology and diagnosisStephen Ross, Eric PeselowPageof 236